Fmr Llc

13F Holdings History for Dianthus Therapeutics, Inc. /DE/ - Common Stock, $0.001 par value (DNTH)

Symbol: DNTH on Nasdaq
Investment type: Equity / Common Stock, $0.001 par value
Latest Disclosed Ownership: 5.97M shares
Security Ownership: 15%

Shares, Excluding Options vs Price

Value, Excluding Options

FMR LLC ownership in Dianthus Therapeutics, Inc. /DE/ Common Stock, $0.001 par value (DNTH)

2025-11-05 - FMR LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5.97M shares of Dianthus Therapeutics, Inc. /DE/ Common Stock, $0.001 par value (DNTH). This represents 15% percent ownership of the company. In their previous filing dated 2025-05-12, FMR LLC had reported owning 4.48M shares, indicating an increase of 33.2% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
FMR LLC	15%	+7.14%	$235M	5.97M	+1,488,029	+33.2%	$39.35	13G/A	9/30/2025	5 Nov 2025 11:30:18
FMR LLC	14%		$69.9M	4.48M			$15.60	13G/A	3/31/2025	12 May 2025 10:28:12

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0.01%	+0%	$235M	5.97M	+1,426,450	+31.4%	$39.35	Q3 2025
6/30/2025	0%	+0%	$84.7M	4.54M	+61,579	+1.37%	$18.63	Q2 2025
3/31/2025	0.01%	+0%	$81.3M	4.48M	+43,328		$18.14	Q1 2025
12/31/2024	0.01%	+0%	$96.8M	4.44M	+36,133	+0.82%	$21.80	Q4 2024
9/30/2024	0.01%	+0%	$121M	4.4M	+728	+0.02%	$27.38	Q3 2024
6/30/2024	0.01%	+0%	$114M	4.4M	+241,375	+5.8%	$25.88	Q2 2024
3/31/2024	0.01%	+0%	$125M	4.16M	+1,942,833	+87.6%	$30.00	Q1 2024
12/31/2023	0%		$22.6M	2.22M			$10.17	Q4 2023
9/30/2023	0%	+0%	$29M	2.22M	+2,218,212	NEW	$13.06	Q3 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.